Global In-vitro Diagnostics (IVD) Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	260 Pages	TechNavio	February, 2025	INF19639178

Best Price Guarantee
Price	from $2,500
Length	260 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19639178

In-Vitro Diagnostics (IVD) Market 2025-2029

The in-vitro diagnostics (IVD) market is forecasted to grow by USD 28.8 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the in-vitro diagnostics (IVD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, chronic and infectious diseases, demand for personalized medicine, and new product launches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - https://www.technavio.com/report/report/in-vitro-diagnostics-market-industry-analysis

Technavio's in-vitro diagnostics (IVD) market is segmented as below:

By Product Type

Reagents and kits
Instruments
Others

By Technology

Immunoassay
Molecular diagnostics
Clinical chemistry
Hematology
Others

By Application

Oncology
Cardiology
Autoimmune diseases
Neurology
Others

By End-user

Hospitals and clinics
Research institutes
Diagnostics laboratories
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the global adoption of advanced treatment solutions as one of the prime reasons driving the in-vitro diagnostics (IVD) market growth during the next few years. Also, innovations in digital in-vitro diagnostics sector and increasing focus on point-of-care molecular diagnostics will lead to sizable demand in the market.

The report on the in-vitro diagnostics (IVD) market covers the following areas:

In-Vitro Diagnostics (IVD) Market sizing
In-Vitro Diagnostics (IVD) Market forecast
In-Vitro Diagnostics (IVD) Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro diagnostics (IVD) market vendors that include Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., BioMerieux SA, Charles River Laboratories International Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Merck KGaA, QIAGEN N.V., Quest Diagnostics Inc., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc.. Also, the in-vitro diagnostics (IVD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product Type; Executive Summary - Chart on Market Segmentation by Technology; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global In-Vitro Diagnostics (IVD) Market 2019 - 2023; Historic Market Size - Data Table on Global In-Vitro Diagnostics (IVD) Market 2019 - 2023 ($ billion); 5.2 Product Type segment analysis 2019 - 2023; Historic Market Size - Product Type Segment 2019 - 2023 ($ billion); 5.3 Technology segment analysis 2019 - 2023; Historic Market Size - Technology Segment 2019 - 2023 ($ billion); 5.4 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ billion); 5.5 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ billion); 5.6 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.7 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on Global In-vitro Diagnostics (IVD) Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product Type: 8.1 Market segments; Chart on Product Type - Market share 2024-2029 (%); Data Table on Product Type - Market share 2024-2029 (%); 8.2 Comparison by Product Type; Chart on Comparison by Product Type; Data Table on Comparison by Product Type; 8.3 Reagents and kits - Market size and forecast 2024-2029; Chart on Reagents and kits - Market size and forecast 2024-2029 ($ billion); Data Table on Reagents and kits - Market size and forecast 2024-2029 ($ billion); Chart on Reagents and kits - Year-over-year growth 2024-2029 (%); Data Table on Reagents and kits - Year-over-year growth 2024-2029 (%); 8.4 Instruments - Market size and forecast 2024-2029; Chart on Instruments - Market size and forecast 2024-2029 ($ billion); Data Table on Instruments - Market size and forecast 2024-2029 ($ billion); Chart on Instruments - Year-over-year growth 2024-2029 (%); Data Table on Instruments - Year-over-year growth 2024-2029 (%); 8.5 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.6 Market opportunity by Product Type; Market opportunity by Product Type ($ billion); Data Table on Market opportunity by Product Type ($ billion)
9 Market Segmentation by Technology: 9.1 Market segments; Chart on Technology - Market share 2024-2029 (%); Data Table on Technology - Market share 2024-2029 (%); 9.2 Comparison by Technology; Chart on Comparison by Technology; Data Table on Comparison by Technology; 9.3 Immunoassay - Market size and forecast 2024-2029; Chart on Immunoassay - Market size and forecast 2024-2029 ($ billion); Data Table on Immunoassay - Market size and forecast 2024-2029 ($ billion); Chart on Immunoassay - Year-over-year growth 2024-2029 (%); Data Table on Immunoassay - Year-over-year growth 2024-2029 (%); 9.4 Molecular diagnostics - Market size and forecast 2024-2029; Chart on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Data Table on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Chart on Molecular diagnostics - Year-over-year growth 2024-2029 (%); Data Table on Molecular diagnostics - Year-over-year growth 2024-2029 (%); 9.5 Clinical chemistry - Market size and forecast 2024-2029; Chart on Clinical chemistry - Market size and forecast 2024-2029 ($ billion); Data Table on Clinical chemistry - Market size and forecast 2024-2029 ($ billion); Chart on Clinical chemistry - Year-over-year growth 2024-2029 (%); Data Table on Clinical chemistry - Year-over-year growth 2024-2029 (%); 9.6 Hematology - Market size and forecast 2024-2029; Chart on Hematology - Market size and forecast 2024-2029 ($ billion); Data Table on Hematology - Market size and forecast 2024-2029 ($ billion); Chart on Hematology - Year-over-year growth 2024-2029 (%); Data Table on Hematology - Year-over-year growth 2024-2029 (%); 9.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.8 Market opportunity by Technology; Market opportunity by Technology ($ billion); Data Table on Market opportunity by Technology ($ billion)
10 Market Segmentation by Application: 10.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 10.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 10.3 Oncology - Market size and forecast 2024-2029; Chart on Oncology - Market size and forecast 2024-2029 ($ billion); Data Table on Oncology - Market size and forecast 2024-2029 ($ billion); Chart on Oncology - Year-over-year growth 2024-2029 (%); Data Table on Oncology - Year-over-year growth 2024-2029 (%); 10.4 Cardiology - Market size and forecast 2024-2029; Chart on Cardiology - Market size and forecast 2024-2029 ($ billion); Data Table on Cardiology - Market size and forecast 2024-2029 ($ billion); Chart on Cardiology - Year-over-year growth 2024-2029 (%); Data Table on Cardiology - Year-over-year growth 2024-2029 (%); 10.5 Autoimmune diseases - Market size and forecast 2024-2029; Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ billion); Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ billion); Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%); Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%); 10.6 Neurology - Market size and forecast 2024-2029; Chart on Neurology - Market size and forecast 2024-2029 ($ billion); Data Table on Neurology - Market size and forecast 2024-2029 ($ billion); Chart on Neurology - Year-over-year growth 2024-2029 (%); Data Table on Neurology - Year-over-year growth 2024-2029 (%); 10.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 10.8 Market opportunity by Application; Market opportunity by Application ($ billion); Data Table on Market opportunity by Application ($ billion)
11 Market Segmentation by End-user: 11.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 11.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 11.3 Hospitals and clinics - Market size and forecast 2024-2029; Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion); Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion); Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%); Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%); 11.4 Research institutes - Market size and forecast 2024-2029; Chart on Research institutes - Market size and forecast 2024-2029 ($ billion); Data Table on Research institutes - Market size and forecast 2024-2029 ($ billion); Chart on Research institutes - Year-over-year growth 2024-2029 (%); Data Table on Research institutes - Year-over-year growth 2024-2029 (%); 11.5 Diagnostics laboratories - Market size and forecast 2024-2029; Chart on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion); Data Table on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion); Chart on Diagnostics laboratories - Year-over-year growth 2024-2029 (%); Data Table on Diagnostics laboratories - Year-over-year growth 2024-2029 (%); 11.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 11.7 Market opportunity by End-user; Market opportunity by End-user ($ billion); Data Table on Market opportunity by End-user ($ billion)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape: 13.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 13.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 13.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 13.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 13.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 13.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 13.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 13.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 13.9 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 13.10 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 13.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 13.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 13.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 13.14 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 13.15 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ billion); Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 13.16 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ billion); Data Table on Brazil - Market size and forecast 2024-2029 ($ billion); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 13.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
14 Drivers, Challenges, and Opportunity/Restraints: 14.1 Market drivers; 14.2 Market challenges; 14.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 14.4 Market opportunities/restraints
15 Competitive Landscape: 15.1 Overview; 15.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 15.3 Landscape disruption; Overview on factors of disruption; 15.4 Industry risks; Impact of key risks on business
16 Competitive Analysis: 16.1 Companies profiled; Companies covered; 16.2 Company ranking index; Company ranking index; 16.3 Market positioning of companies; Matrix on companies position and classification; 16.4 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; SWOT; 16.5 Agilent Technologies Inc.; Agilent Technologies Inc. - Overview; Agilent Technologies Inc. - Business segments; Agilent Technologies Inc. - Key news; Agilent Technologies Inc. - Key offerings; Agilent Technologies Inc. - Segment focus; SWOT; 16.6 ARKRAY Inc.; ARKRAY Inc. - Overview; ARKRAY Inc. - Product / Service; ARKRAY Inc. - Key offerings; SWOT; 16.7 Becton Dickinson and Co.; Becton Dickinson and Co. - Overview; Becton Dickinson and Co. - Business segments; Becton Dickinson and Co. - Key news; Becton Dickinson and Co. - Key offerings; Becton Dickinson and Co. - Segment focus; SWOT; 16.8 BGI Genomics Co. Ltd.; BGI Genomics Co. Ltd. - Overview; BGI Genomics Co. Ltd. - Product / Service; BGI Genomics Co. Ltd. - Key offerings; SWOT; 16.9 Bio Rad Laboratories Inc.; Bio Rad Laboratories Inc. - Overview; Bio Rad Laboratories Inc. - Business segments; Bio Rad Laboratories Inc. - Key news; Bio Rad Laboratories Inc. - Key offerings; Bio Rad Laboratories Inc. - Segment focus; SWOT; 16.10 BioMerieux SA; BioMerieux SA - Overview; BioMerieux SA - Business segments; BioMerieux SA - Key news; BioMerieux SA - Key offerings; BioMerieux SA - Segment focus; SWOT; 16.11 Danaher Corp.; Danaher Corp. - Overview; Danaher Corp. - Business segments; Danaher Corp. - Key news; Danaher Corp. - Key offerings; Danaher Corp. - Segment focus; SWOT; 16.12 DiaSorin SpA; DiaSorin SpA - Overview; DiaSorin SpA - Business segments; DiaSorin SpA - Key news; DiaSorin SpA - Key offerings; DiaSorin SpA - Segment focus; SWOT; 16.13 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 16.14 Grifols SA; Grifols SA - Overview; Grifols SA - Business segments; Grifols SA - Key news; Grifols SA - Key offerings; Grifols SA - Segment focus; SWOT; 16.15 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; SWOT; 16.16 QIAGEN N.V.; QIAGEN N.V. - Overview; QIAGEN N.V. - Product / Service; QIAGEN N.V. - Key news; QIAGEN N.V. - Key offerings; SWOT; 16.17 Quest Diagnostics Inc.; Quest Diagnostics Inc. - Overview; Quest Diagnostics Inc. - Business segments; Quest Diagnostics Inc. - Key offerings; Quest Diagnostics Inc. - Segment focus; SWOT; 16.18 QuidelOrtho Corp.; QuidelOrtho Corp. - Overview; QuidelOrtho Corp. - Product / Service; QuidelOrtho Corp. - Key offerings; SWOT
17 Appendix: 17.1 Scope of the report; 17.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 17.3 Currency conversion rates for US$; Currency conversion rates for US$; 17.4 Research methodology; Research methodology; 17.5 Data procurement; Information sources; 17.6 Data validation; Data validation; 17.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 17.8 Data synthesis; Data synthesis; 17.9 360 degree market analysis; 360 degree market analysis; 17.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Technology; Exhibits7: Executive Summary - Chart on Market Segmentation by Application; Exhibits8: Executive Summary - Chart on Market Segmentation by End-user; Exhibits9: Executive Summary - Chart on Incremental Growth; Exhibits10: Executive Summary - Data Table on Incremental Growth; Exhibits11: Executive Summary - Chart on Company Market Positioning; Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits13: Overview on criticality of inputs and factors of differentiation; Exhibits14: Overview on factors of disruption; Exhibits15: Impact of drivers and challenges in 2024 and 2029; Exhibits16: Parent Market; Exhibits17: Data Table on - Parent Market; Exhibits18: Market characteristics analysis; Exhibits19: Value chain analysis; Exhibits20: Offerings of companies included in the market definition; Exhibits21: Market segments; Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits26: Historic Market Size - Data Table on Global In-Vitro Diagnostics (IVD) Market 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Product Type Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Technology Segment 2019 - 2023 ($ billion); Exhibits29: Historic Market Size - Application Segment 2019 - 2023 ($ billion); Exhibits30: Historic Market Size - End-user Segment 2019 - 2023 ($ billion); Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits33: Five forces analysis - Comparison between 2024 and 2029; Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits39: Chart on Market condition - Five forces 2024 and 2029; Exhibits40: Chart on Product Type - Market share 2024-2029 (%); Exhibits41: Data Table on Product Type - Market share 2024-2029 (%); Exhibits42: Chart on Comparison by Product Type; Exhibits43: Data Table on Comparison by Product Type; Exhibits44: Chart on Reagents and kits - Market size and forecast 2024-2029 ($ billion); Exhibits45: Data Table on Reagents and kits - Market size and forecast 2024-2029 ($ billion); Exhibits46: Chart on Reagents and kits - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Reagents and kits - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Instruments - Market size and forecast 2024-2029 ($ billion); Exhibits49: Data Table on Instruments - Market size and forecast 2024-2029 ($ billion); Exhibits50: Chart on Instruments - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Instruments - Year-over-year growth 2024-2029 (%); Exhibits52: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits53: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits54: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits55: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits56: Market opportunity by Product Type ($ billion); Exhibits57: Data Table on Market opportunity by Product Type ($ billion); Exhibits58: Chart on Technology - Market share 2024-2029 (%); Exhibits59: Data Table on Technology - Market share 2024-2029 (%); Exhibits60: Chart on Comparison by Technology; Exhibits61: Data Table on Comparison by Technology; Exhibits62: Chart on Immunoassay - Market size and forecast 2024-2029 ($ billion); Exhibits63: Data Table on Immunoassay - Market size and forecast 2024-2029 ($ billion); Exhibits64: Chart on Immunoassay - Year-over-year growth 2024-2029 (%); Exhibits65: Data Table on Immunoassay - Year-over-year growth 2024-2029 (%); Exhibits66: Chart on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits67: Data Table on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits68: Chart on Molecular diagnostics - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Molecular diagnostics - Year-over-year growth 2024-2029 (%); Exhibits70: Chart on Clinical chemistry - Market size and forecast 2024-2029 ($ billion); Exhibits71: Data Table on Clinical chemistry - Market size and forecast 2024-2029 ($ billion); Exhibits72: Chart on Clinical chemistry - Year-over-year growth 2024-2029 (%); Exhibits73: Data Table on Clinical chemistry - Year-over-year growth 2024-2029 (%); Exhibits74: Chart on Hematology - Market size and forecast 2024-2029 ($ billion); Exhibits75: Data Table on Hematology - Market size and forecast 2024-2029 ($ billion); Exhibits76: Chart on Hematology - Year-over-year growth 2024-2029 (%); Exhibits77: Data Table on Hematology - Year-over-year growth 2024-2029 (%); Exhibits78: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits79: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits80: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits82: Market opportunity by Technology ($ billion); Exhibits83: Data Table on Market opportunity by Technology ($ billion); Exhibits84: Chart on Application - Market share 2024-2029 (%); Exhibits85: Data Table on Application - Market share 2024-2029 (%); Exhibits86: Chart on Comparison by Application; Exhibits87: Data Table on Comparison by Application; Exhibits88: Chart on Oncology - Market size and forecast 2024-2029 ($ billion); Exhibits89: Data Table on Oncology - Market size and forecast 2024-2029 ($ billion); Exhibits90: Chart on Oncology - Year-over-year growth 2024-2029 (%); Exhibits91: Data Table on Oncology - Year-over-year growth 2024-2029 (%); Exhibits92: Chart on Cardiology - Market size and forecast 2024-2029 ($ billion); Exhibits93: Data Table on Cardiology - Market size and forecast 2024-2029 ($ billion); Exhibits94: Chart on Cardiology - Year-over-year growth 2024-2029 (%); Exhibits95: Data Table on Cardiology - Year-over-year growth 2024-2029 (%); Exhibits96: Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ billion); Exhibits97: Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ billion); Exhibits98: Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%); Exhibits99: Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%); Exhibits100: Chart on Neurology - Market size and forecast 2024-2029 ($ billion); Exhibits101: Data Table on Neurology - Market size and forecast 2024-2029 ($ billion); Exhibits102: Chart on Neurology - Year-over-year growth 2024-2029 (%); Exhibits103: Data Table on Neurology - Year-over-year growth 2024-2029 (%); Exhibits104: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits105: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits106: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits107: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits108: Market opportunity by Application ($ billion); Exhibits109: Data Table on Market opportunity by Application ($ billion); Exhibits110: Chart on End-user - Market share 2024-2029 (%); Exhibits111: Data Table on End-user - Market share 2024-2029 (%); Exhibits112: Chart on Comparison by End-user; Exhibits113: Data Table on Comparison by End-user; Exhibits114: Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion); Exhibits115: Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion); Exhibits116: Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%); Exhibits117: Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%); Exhibits118: Chart on Research institutes - Market size and forecast 2024-2029 ($ billion); Exhibits119: Data Table on Research institutes - Market size and forecast 2024-2029 ($ billion); Exhibits120: Chart on Research institutes - Year-over-year growth 2024-2029 (%)